Cargando…
A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy
CONTEXT: Androgen deprivation therapy (ADT) in prostate cancer results in muscular atrophy, due to loss of the anabolic actions of testosterone. Recently, we discovered that testosterone acts on the hepatic urea cycle to reduce amino acid nitrogen elimination. We now hypothesize that ADT enhances pr...
Autores principales: | Lam, Teresa, McLean, Mark, Hayden, Amy, Poljak, Anne, Cheema, Birinder, Gurney, Howard, Stone, Glenn, Bahl, Neha, Reddy, Navneeta, Shahidipour, Haleh, Birzniece, Vita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510709/ https://www.ncbi.nlm.nih.gov/pubmed/30991356 http://dx.doi.org/10.1530/EC-19-0179 |
Ejemplares similares
-
Androgen deprivation in prostate cancer: benefits of home-based resistance training
por: Lam, Teresa, et al.
Publicado: (2020) -
The Adverse Effects of Androgen Deprivation Therapy in Prostate Cancer and the Benefits and Potential Anti-oncogenic Mechanisms of Progressive Resistance Training
por: Lam, Teresa, et al.
Publicado: (2020) -
Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients
por: Birzniece, Vita, et al.
Publicado: (2022) -
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022) -
The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)